Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Breast Cancer, Male

fluorodeoxyglucose f18 has been researched along with Breast Cancer, Male in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.13)18.2507
2000's6 (18.75)29.6817
2010's24 (75.00)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Li, W; Shi, W1
Bryce, R; Dujka, M; Hyman, DM; Jhaveri, K; Mann, G; Mayer, I; Meric-Bernstam, F; Piha-Paul, SA; Quinn, D; Saura, C; Shahin, S; Solit, DB; Stone, B; Ulaner, GA1
Kawajiri, H; Miyashita, M; Takada, K1
Huang, J; Qu, S; Wang, T1
Bal, A; Basher, RK; Bhattacharya, A; Kapoor, R; Mittal, BR; Parihar, AS; Singh, G; Sood, A; Vadi, SK1
Anemona, L; Buonomo, OC; Caredda, E; Chiaravalloti, A; Marchese, PV; Orsaria, P; Palombi, L; Petrella, G; Portarena, I; Schillaci, O; Titka, B1
Aliyev, A; Arslan, E; Ekmekcioglu, O; Erkan, ME; Halac, M; Kaya, R; Kocael, P; Sonmezoglu, K; Yilmaz, S1
Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR1
Bousquet, G; Espié, M; Groheux, D; Hindié, E; Marty, M; Merlet, P; Misset, JL; Ohnona, J; Rubello, D; Toubert, ME; Vercellino, L1
Alsharabati, M; Oh, SJ1
Bertagna, F; Bertoli, M; Evangelista, L; Giubbini, R; Saladini, G; Stela, T1
Canpolat, T; Erhamamci, S; Nursal, GN; Reyhan, M; Yapar, AF1
Babb, JS; Jhaveri, K; Kim, SG; Melsaether, AN; Moy, LA; Ponzo, FD; Pujara, AC; Pysarenko, KM; Raad, RA; Sigmund, EE1
Currin, ER; Krohn, KA; Kurland, BF; Lee, JH; Linden, HM; Link, JM; Mankoff, DA; Peterson, LM; Schubert, EK1
Halaç, M; Ilvan, Ş; Işik, G; Kocael, P; Kuyumcu, S; Sağer, S; Sönmezoğlu, K; Türkmen, C; Vatankulu, B1
Gauthé, M; Gilbeau, L; Hugentobler, A; Talbot, JN1
Kuo, PH; McEachen, JC1
Behr, TM; Gratz, S; Höffken, H; Kaiser, W; Kempke, B; Pfestroff, A1
Che, WJ; Qiao, WL; Wang, TS; Xing, Y; Zhao, JH1
Chung, A; Morrow, M; Port, E; Sampson, M; Schoder, H1
Ambrózay, E; Forrai, G; Milics, M; Ormándi, K; Péntek, Z; Rajtár, M; Sinkovics, I; Szabó, E1
De Ridder, M; Everaert, H; Fontaine, C; Lamote, J; Ratib, O; van Parijs, H; Vanhoeij, M; Vees, H; Verfaillie, G; Vinh-Hung, V; Vlastos, G; Voordeckers, M1
De Cicco, C; Gilardi, L; Paganelli, G1
Chua, S; Groves, AM1
Antoch, G; Bockisch, A; Forsting, M; Hartung, V; Heusner, TA; Kimmig, R; Koeninger, A; Otterbach, F; Riegger, C1
Baretta, Z; Bezzon, E; Cervino, AR; De Carolis, V; Evangelista, L; Ghiotto, C; Gregianin, M; Muzzio, PC; Pomerri, F; Saladini, G; Vinante, L1
Kon, M; Kuwana, K; Sueoka, N; Tsubota, Y; Yamamoto, D1
Abolmaali, N; Froehner, M; Wirth, MP1
Basu, S; Nair, N1
Groshar, D; Gurion, R; Raanani, P; Schindel, A; Shpilberg, O1
Adler, LP; Crowe, JP; Shenk, RR; Sunshine, J1
Austin-Seymour, MM; Charlop, A; Eary, JF; Ellis, GK; Eubank, WB; Funkhouser, CP; Gralow, JR; Lindsley, KL; Livingston, RB; Mankoff, DA; Shanley, TJ; Takasugi, J; Vesselle, H1

Trials

3 trial(s) available for fluorodeoxyglucose f18 and Breast Cancer, Male

ArticleYear
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 12-15, Volume: 25, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Selection; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Radiopharmaceuticals; Receptor, ErbB-2; Response Evaluation Criteria in Solid Tumors; Treatment Outcome

2019
Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
    Anticancer research, 2018, Volume: 38, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity

2018
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Aug-01, Volume: 19, Issue:15

    Topics: Adult; Aged; Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prevalence; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed

2001

Other Studies

29 other study(ies) available for fluorodeoxyglucose f18 and Breast Cancer, Male

ArticleYear
An incidental male breast cancer of
    Asian journal of surgery, 2023, Volume: 46, Issue:4

    Topics: Breast Neoplasms; Breast Neoplasms, Male; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2023
[A Case of an Elderly Male with Breast Cancer with Synchronous Triple Cancer of the Lung and Stomach].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13

    Topics: Aged, 80 and over; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lung Neoplasms; Male; Mastectomy; Neoplasms, Multiple Primary; Stomach Neoplasms

2019
Presence of the minor allele of microRNA205 rs3842530 polymorphism increases 18FDG uptake in patients with breast cancer via targeting VEGF.
    Molecular medicine reports, 2018, Volume: 17, Issue:1

    Topics: 3' Untranslated Regions; Alleles; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; MCF-7 Cells; MicroRNAs; Middle Aged; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Vascular Endothelial Growth Factor A

2018
Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer.
    Nuclear medicine communications, 2019, Volume: 40, Issue:1

    Topics: Adult; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies

2019
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
    Nuclear medicine communications, 2013, Volume: 34, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed

2013
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
    Breast cancer (Tokyo, Japan), 2016, Volume: 23, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult

2016
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
    European journal of radiology, 2014, Volume: 83, Issue:10

    Topics: Adult; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging

2014
Paraneoplastic myeloneuropathy in a man with breast cancer.
    Muscle & nerve, 2015, Volume: 52, Issue:4

    Topics: Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Paraneoplastic Polyneuropathy; Positron-Emission Tomography

2015
Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population.
    Current radiopharmaceuticals, 2016, Volume: 9, Issue:2

    Topics: Aged; Aged, 80 and over; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals

2016
A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2016
Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Radiology, 2016, Volume: 281, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Whole Body Imaging

2016
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-15, Volume: 23, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Breast Neoplasms, Male; Disease-Free Survival; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2

2017
Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
    Nuclear medicine communications, 2016, Volume: 37, Issue:12

    Topics: Aged; Aged, 80 and over; Breast Neoplasms, Male; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies

2016
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:1

    Topics: Aged; Breast Neoplasms, Male; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
Male primary breast cancer found on FDG-PET/CT.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:9

    Topics: Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging

2008
Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
    Nuclear medicine communications, 2008, Volume: 29, Issue:11

    Topics: Aged; Breast Neoplasms, Male; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

2008
[The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:2

    Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging

2009
Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
    Annals of surgical oncology, 2010, Volume: 17, Issue:8

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult

2010
[Imaging methods in the current diagnosis of and screening for breast cancer].
    Magyar onkologia, 2010, Volume: 54, Issue:3

    Topics: Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Mass Screening; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary

2010
Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:10

    Topics: Adult; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies

2012
Preoperative FDG PET/CT in breast cancer patients: where are we going?
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:11

    Topics: Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals

2012
Pretreatment PET in breast cancer: is there a role?
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:12

    Topics: Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals

2012
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
    Acta radiologica (Stockholm, Sweden : 1987), 2012, Dec-01, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography

2012
Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2012, Volume: 56, Issue:4

    Topics: Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed

2012
[The utility of FDG-PET/CT for pre/post operative diagnosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 7

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Postoperative Period; Preoperative Period; Tomography, X-Ray Computed

2012
Prostate-specific antigen-negative prostate cancer recurrence?
    Urology, 2013, Volume: 81, Issue:2

    Topics: Aged; Bone Neoplasms; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed

2013
Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PET.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:4

    Topics: Adult; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Soft Tissue Neoplasms; Upper Extremity

2005
18F-fluorodeoxyglucose-Avid mammary mass in a patient with insulin-dependent diabetes mellitus and Hodgkin's lymphoma: relapse or pitfall?
    The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:12

    Topics: Adult; Breast Neoplasms, Male; Diabetes Complications; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed

2006
Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.
    Annals of surgical oncology, 1994, Volume: 1, Issue:2

    Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mammography; Middle Aged; Tomography, Emission-Computed

1994